Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 310,588
  • Shares Outstanding, K 300,085
  • Annual Sales, $ 154,010 K
  • Annual Income, $ -309,850 K
  • EBIT $ -196 M
  • EBITDA $ -47 M
  • 60-Month Beta 2.19
  • Price/Sales 2.07
  • Price/Cash Flow N/A
  • Price/Book 3.47

Options Overview Details

View History
  • Implied Volatility 92.38% ( -24.39%)
  • Historical Volatility 82.42%
  • IV Percentile 3%
  • IV Rank 3.57%
  • IV High 412.87% on 04/16/25
  • IV Low 80.53% on 06/03/24
  • Put/Call Vol Ratio 0.28
  • Today's Volume 3,950
  • Volume Avg (30-Day) 2,329
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 141,609
  • Open Int (30-Day) 125,404

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.18
  • Number of Estimates 4
  • High Estimate -0.17
  • Low Estimate -0.20
  • Prior Year -0.20
  • Growth Rate Est. (year over year) +10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9501 +8.94%
on 05/16/25
1.2500 -17.20%
on 04/23/25
-0.1650 (-13.75%)
since 04/16/25
3-Month
0.9501 +8.94%
on 05/16/25
2.0100 -48.51%
on 02/18/25
-0.8150 (-44.05%)
since 02/14/25
52-Week
0.9501 +8.94%
on 05/16/25
2.7200 -61.95%
on 11/07/24
-1.1550 (-52.74%)
since 05/16/24

Most Recent Stories

More News
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated

PACB : 1.0350 (-2.36%)
Pacific Biosciences: Q1 Earnings Snapshot

Pacific Biosciences: Q1 Earnings Snapshot

PACB : 1.0350 (-2.36%)
PacBio Announces First Quarter 2025 Financial Results

PACB : 1.0350 (-2.36%)
First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand

PACB : 1.0350 (-2.36%)
PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry

PACB : 1.0350 (-2.36%)
1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar

1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar

ARHS : 8.66 (+3.34%)
PACB : 1.0350 (-2.36%)
DASH : 202.00 (+2.49%)
Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa

PACB : 1.0350 (-2.36%)
Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

Q4 Rundown: Illumina (NASDAQ:ILMN) Vs Other Life Sciences Tools & Services Stocks

TECH : 49.15 (+1.89%)
PACB : 1.0350 (-2.36%)
ILMN : 83.62 (+3.36%)
BRKR : 37.53 (+2.29%)
DHR : 196.11 (+2.70%)
PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know

TXG : 9.39 (+2.07%)
PACB : 1.0350 (-2.36%)
HIMS : 64.65 (+10.36%)
MRNA : 24.86 (+5.12%)
PacBio Stock Soars On Plans To Reduce Spending Over NIH Funding Uncertainty, Tariffs: Retail Is Overjoyed

The company said that the decision is in response to uncertainty surrounding academic and National Institutes of Health (NIH) funding and the introduction of new tariffs under the Trump administration....

PACB : 1.0350 (-2.36%)
VTI : 292.58 (+0.68%)
IWM : 209.85 (+0.83%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 1.1899
2nd Resistance Point 1.1249
1st Resistance Point 1.0800
Last Price 1.0350
1st Support Level 0.9701
2nd Support Level 0.9051
3rd Support Level 0.8602

See More

52-Week High 2.7200
Fibonacci 61.8% 2.0439
Fibonacci 50% 1.8350
Fibonacci 38.2% 1.6262
Last Price 1.0350
52-Week Low 0.9501

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »